An Update on Pulmonary Arterial Hypertension

被引：7
作者：
Wapner, Joanna [1 ]
Matura, Lea Ann [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 05期
关键词：
diagnosis; pathophysiology; pulmonary arterial hypertension; treatment; ORAL TREPROSTINIL; MANAGEMENT; DIAGNOSIS; THERAPY; DISEASE;
D O I：
10.1016/j.nurpra.2015.02.004
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Pulmonary arterial hypertension (PAH) is a progressive disease that ultimately leads to right heart failure and death. PAH is defined as a mean pulmonary arterial pressure >= 25 mmHg with a pulmonary capillary wedge pressure <= 15 mmHg at rest. The diagnosis of PAH is one of exclusion; diagnostics include an extensive history, serology, chest radiograph, pulmonary function tests, ventilation/perfusion scan, transthoracic echocardiogram, and right heart catheterization. Treatment and care of patients with PAH can be complex. Therefore, the nurse practitioner is an integral member of the health care team caring for PAH patients, helping to ensure seamless care and support. (C) 2015 Elsevier, Inc. All rights reserved.
引用
收藏
页码：551 / 559
页数：9
相关论文
共 50 条
  • [21] Screening of Pulmonary Arterial Hypertension
    Lau, Edmund M. T.
    Celermajer, David S.
    Keogh, Anne
    Thakkar, Vivek
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (05) : 596 - 605
  • [22] Update on pulmonary arterial hypertension research: proceedings from a meeting of experts
    McLaughlin, Vallerie
    Bacchetta, Matthew
    Badesch, David
    Benza, Raymond
    Burger, Charles
    Chin, Kelly
    Frantz, Robert
    Frost, Adaani
    Hemnes, Anna
    Kim, Nick H.
    Rosenzweig, Erika B.
    Rubin, Lewis
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 263 - 273
  • [23] Quality of life as a prognostic marker in pulmonary arterial hypertension
    Fernandes, Caio J. C. S.
    Martins, Barbara C. S.
    Jardim, Carlos V. P.
    Ciconelli, Rozana M.
    Morinaga, Luciana K.
    Breda, Ana Paula
    Hoette, Susana
    Souza, Rogerio
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [24] Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes
    Elshaboury, Soha M.
    Anderson, Joe R.
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 401 - 409
  • [25] Pulmonary arterial hypertension and statins: an update
    Katsiki, Niki
    Wierzbicki, Anthony S.
    Mikhailidis, Dimitri P.
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 (04) : 322 - 326
  • [26] Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
    Vraka, Argyro
    Diamanti, Eleni
    Kularatne, Mithum
    Yerly, Patrick
    Lador, Frederic
    Aubert, John-David
    Lechartier, Benoit
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [27] Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension
    Tamura, Yuichi
    Kumamaru, Hiraku
    Satoh, Toru
    Miyata, Hiroaki
    Ogawa, Aiko
    Tanabe, Nobuhiro
    Hatano, Masaru
    Yao, Atsushi
    Abe, Kohtaro
    Tsujino, Ichizo
    Fukuda, Keiichi
    Kimura, Hiroshi
    Kuwana, Masataka
    Matsubara, Hiromi
    Tatsumi, Koichiro
    CIRCULATION JOURNAL, 2018, 82 (01) : 275 - U346
  • [28] Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update
    James C. Coons
    Kristen Pogue
    Andrew R. Kolodziej
    Glenn A. Hirsch
    Marjorie Patricia George
    Current Cardiology Reports, 2019, 21
  • [29] Pulmonary arterial hypertension: diagnosis and treatment
    Sadowski, Marcin
    Janion-Sadowska, Agnieszka
    Letek, Agnieszka
    Raczynski, Grzegorz
    Zandecki, Lukasz
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2013, 29 (03) : 273 - 279
  • [30] Macitentan for the Treatment of Pulmonary Arterial Hypertension
    Hong, Irene S.
    Coe, Holly V.
    Catanzaro, Linda M.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (04) : 538 - 547
12345